Novo Nordisk A/S (NOVC.DE) XETRA

91.40

-1.85(-1.98%)

Updated at November 14, 2023 04:35PM

Currency In EUR

Valuation

Market Cap3.06T
Enterprise Value3.07T
P/E Ratio10.11
PEG Ratio0.61
Price/Sales Ratio3.76
Price/Book Ratio6.07
Enterprise/Revenue4.14
Enterprise/EBITDA7.39

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin0.37
Operating Margin0.45

Management Effectiveness

Return On Assets0.22
Return On Equity0.66

Income Statement

Revenue232.26B
Revenue/Share73.79
Gross Profit196.5B
EBITDA114.63B
Net Income83.68B
Diluted EPS18.62

Balance Sheet

Total Cash74.88B
Total Cash/Share4.87
Total Debt56.97B
Total Debt/Equity0.72
Current Ratio0.79
Book Value Per Share45.71

Price History

52-Week Change69.64
52-Week High185.12
52-Week Low51.65
Moving Average 50 Days85.46
Moving Average 200 Days74.38

Statistics

Average Volume51,037
Shares Outstanding4.45B
% Held by Institutions0.01

Dividend And Splits

Trailing Annual Dividend Rate11.7
Trailing Annual Dividend Yield4.21
Payout Ratio0.42
Last Split Factor2:1
Last Split DateSeptember 13, 2023